3w3 min read
Medical Article
Introduction Lung cancer remains the leading cause of cancer-related mortality worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all cases (1). Prognosis is particularly poor in patients with advanced stage IV disease, especially when tumors lack actionable driver mutations such as epidermal growth factor recept

Case Report: Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
Similar Content

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

Safe Ramadan Practices during COVID-19 - WHO Guidance
6543 Reached8 Comments3 Likes

How Physicians Should Manage Stress?
35340 Reached151 Comments202 Likes

A Case Study On Airway Management Of CPAM Resection In Neonates
336 Reached
